Verastem (VSTM) Interest & Investment Income (2012 - 2026)
Verastem's (VSTM) quarterly Interest & Investment Income came in at $1.3 million in Q1 2026, up 35.1% year-on-year from $960000.0 in Q1 2025, and up 17.48% quarter-over-quarter from $1.1 million in Q4 2025.
Verastem (VSTM) Interest & Investment Income (2012 - 2026) Analysis & Trends
Verastem's Interest & Investment Income history runs 15 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 35.1% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 17.72% increase from a year earlier, with the FY2025 full-year figure at $4.1 million, down 1.95% from the prior year.
- Interest & Investment Income grew to $1.3 million in Q1 2026 per VSTM's latest filing, from $1.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.2 million in Q3 2023 and bottomed at $46000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $976000.0 (2023), against an average of $996647.1.
- Across the five-year window, Interest & Investment Income surged 2021.74% in 2023 and slumped 63.02% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $769000.0 in 2022, then jumped by 143.04% to $1.9 million in 2023, then plunged by 48.21% to $968000.0 in 2024, then advanced by 14.05% to $1.1 million in 2025, then gained by 17.48% to $1.3 million in 2026.
- Per Business Quant, the three latest VSTM Interest & Investment Income figures stand at $1.3 million (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Verastem | 607.94 Mn | 410.11 Mn | 15.90 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 822,000.00 |
| Mar 31, 2025 | 960,000.00 |
| Dec 31, 2024 | 968,000.00 |
| Sep 30, 2024 | 831,000.00 |
| Jun 30, 2024 | 983,000.00 |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 976,000.00 |
| Dec 31, 2022 | 769,000.00 |
| Sep 30, 2022 | 316,000.00 |
| Jun 30, 2022 | 84,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 40,000.00 |
| Jun 30, 2021 | 49,000.00 |